D.A. Davidson & Co’s Takeda Pharmaceutical TAK Stock Holding History

D.A. Davidson & Co’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,721	Closed	-$180K	–	1239
2021 Q2	$180K	Sell	10,721 -3,490	-25%	-$59.4K	﹤0.01%	1139
2021 Q1	$259K	Buy	+14,211	New	+$256K	﹤0.01%	1006
2020 Q2	–	Sell	-19,830	Closed	-$301K	–	1017
2020 Q1	$301K	Sell	19,830 -2,830	-12%	-$51.3K	0.01%	746
2019 Q4	$447K	Buy	22,660 +1,745	+8%	+$33.4K	0.01%	708
2019 Q3	$360K	Sell	20,915 -15,691	-43%	-$271K	0.01%	739
2019 Q2	$648K	Sell	36,606 -2,231	-6%	-$40.6K	0.01%	572
2019 Q1	$791K	Buy	+38,837	New	+$782K	0.01%	560

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.A. Davidson & Co's TAK Position: Q3 2021 in Review

D.A. Davidson & Co sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 10,721 shares — an estimated $180K sold.

D.A. Davidson & Co first reported a position in TAK in Q1 2019 and held it in 7 quarters. The position peaked at $791K in Q1 2019. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

D.A. Davidson & Co reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
D.A. Davidson & Co sold 10,721 Takeda Pharmaceutical shares in Q3 2021, an estimated $180K.
D.A. Davidson & Co first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 7 quarters.
D.A. Davidson & Co's Takeda Pharmaceutical position peaked at $791K in Q1 2019.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on D.A. Davidson & Co's 13F filing for Q3 2021, filed 15 Nov 2021.